Phase II trial of intraperitoneal (IP) MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with ovarian carcinoma (OC) with minimal or microscopic residual disease at second look laparotomy/laparoscopy
Titel:
Phase II trial of intraperitoneal (IP) MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with ovarian carcinoma (OC) with minimal or microscopic residual disease at second look laparotomy/laparoscopy
Auteur:
Conte, P.F. Accoto, M. Nannipieri, F. Baretta, Z. Baldoni, A. Bonanno, L. Guarneri, V. Tasca, G. Di Liso, E. Trasciatti, S.